xCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers
Open Access
- 20 February 2021
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 10 (2), 317
- https://doi.org/10.3390/antiox10020317
Abstract
Inducers of ferroptosis such as the glutathione depleting agent Erastin and the GPX4 inhibitor Rsl-3 are being actively explored as potential therapeutics in various cancers, but the factors that determine their sensitivity are poorly understood. Here, we show that expression levels of both subunits of the cystine/glutamate antiporter xCT determine the expression of GPX4 in breast cancer, and that upregulation of the xCT/selenocysteine biosynthesis/GPX4 production axis paradoxically renders the cancer cells more sensitive to certain types of ferroptotic stimuli. We find that GPX4 is strongly upregulated in a subset of breast cancer tissues compared to matched normal samples, and that this is tightly correlated with the increased expression of the xCT subunits SLC7A11 and SLC3A2. Erastin depletes levels of the antioxidant selenoproteins GPX4 and GPX1 in breast cancer cells by inhibiting xCT-dependent extracellular reduction which is required for selenium uptake and selenocysteine biosynthesis. Unexpectedly, while breast cancer cells are resistant compared to nontransformed cells against oxidative stress inducing drugs, at the same time they are hypersensitive to lipid peroxidation and ferroptosis induced by Erastin or Rsl-3, indicating that they are ‘addicted’ to the xCT/GPX4 axis. Our findings provide a strategic basis for targeting the anti-ferroptotic machinery of breast cancer cells depending on their xCT status, which can be further explored.Funding Information
- Suh Kyungbae Foundation (2017)
This publication has 36 references indexed in Scilit:
- Selenoproteins: Molecular Pathways and Physiological RolesPhysiological Reviews, 2014
- Management of Common Adverse Events in Patients Treated With Sorafenib: Nurse and Pharmacist PerspectiveSeminars in Oncology, 2014
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- xCT, component of cysteine/glutamate transporter, as an independent prognostic factor in human esophageal squamous cell carcinomaThe Esophagus, 2013
- Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinomaOncology Reports, 2012
- Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer NetworkCancer, 2012
- Extracellular thiol-assisted selenium uptake dependent on the x c − cystine transporter explains the cancer-specific cytotoxicity of seleniteProceedings of the National Academy of Sciences of the United States of America, 2009
- Selenium: its role as antioxidant in human healthEnvironmental Health and Preventive Medicine, 2008
- MECHANISM AND REGULATION OF SELENOPROTEIN SYNTHESISAnnual Review of Nutrition, 2003
- Amino acid transport systemsNature, 1984